CNN Situation Room With Wolf Blitzer November 12, 2015 23:54:00
For called "squamous adnon-small cell",er previously treated with platinum-based chemotherapy, its not every day something this big comes along. a chance to live longer with... opdivo, nivolumab. opdivo is the first and only immunotherapy fda approved based on a clinical trial demonstrating longer life... ...for these patients. in fact, opdivo significantly increased the chance of living longer versus chemotherapy. opdivo is different. it works with your immune system. opdivo can cause your immu...
Source: archive.org